EIDD-2749
EIDD-2749 (4′-Fluorouridine) is an orally active RdRp inhibitor. EIDD-2749 effectively blocks the replication of RSV and SARS-CoV-2. EIDD-2749 also exhibits activity against HCV and lymphocytic choriomeningitis virus (LCMV). EIDD-2749 is a promising oral therapeutic candidate for COVID-19 and is also suitable for research on other RNA viruses.
| Trivial name | 4'-FlU, 4'-Fluorouridine |
| Catalog Number | E7983 |
| Molecular Formula | C22H19N5O |
| CAS# | 1613589-24-4 |
| Inchi | InChI=1S/C22H19N5O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,23,28) |
| Inchi Key | IVRXNBXKWIJUQB-UHFFFAOYSA-N |
| SMILES | CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/eidd-2749.html |
| Additional Information | https://file.selleck.cn/downloads/struct/e7983-eidd-2749-chemical-structure-tube.png |